Indeed, increased levels of IL-17 mRNA and IL-17 secreting CD4+ T cells were detected in the blood, CSF, and brain lesions of MS patients (Matusevicius et al., 1999; Lock et al., 2002; Tzartos et al., 2008; Durelli et al., 2009). This evidence concerns the gene IL17A and myeloid sarcoma.